BANF vs BRK-B
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BANF has a weak Piotroski F-Score of 4/9, indicating marginal financial health, and lacks an Altman Z-Score, limiting distress risk assessment. Despite solid profitability metrics like a 35.64% profit margin and 14.11% ROE, recent earnings growth has slowed with a -5.4% Q/Q EPS decline and only 4.2% YoY growth. The stock trades above both the Graham Number ($88.52) and intrinsic value estimate ($101.23) at $108.47, reflecting modest overvaluation. Mixed analyst sentiment (Hold) and bearish insider activity further support a neutral stance.
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
Compare Another Pair
Related Comparisons
BANF vs BRK-B: Head-to-Head Comparison
This page compares BancFirst Corporation (BANF) and Berkshire Hathaway Inc. (BRK-B) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.